Statements (76)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Libtayo
|
| gptkbp:analyzes |
therapeutic efficacy
therapeutic applications clinical implications safety profiles |
| gptkbp:associated_with |
immune tolerance
|
| gptkbp:can_be_extended_by |
patients
|
| gptkbp:can_be_used_with |
other therapies
antigens |
| gptkbp:established |
other Ig G subclasses
|
| gptkbp:has_method |
neutralization of pathogens
|
| gptkbp:has_style |
Ig G subclass
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ig G4 monoclonal antibody
|
| gptkbp:is_analyzed_in |
immune function
immune system immune disorders immune status |
| gptkbp:is_associated_with |
gptkb:Ig_G4-related_sclerosing_disease
gptkb:healthcare_organization treatment response clinical outcomes reduced inflammation |
| gptkbp:is_characterized_by |
lack of complement activation
low affinity |
| gptkbp:is_considered |
treatment protocols
treatment guidelines future therapies |
| gptkbp:is_considered_as |
a treatment option
|
| gptkbp:is_evaluated_by |
clinical settings
safety and efficacy clinical applications therapeutic potential |
| gptkbp:is_involved_in |
allergic reactions
autoimmune diseases |
| gptkbp:is_known_for |
its unique structure
modulate immune responses |
| gptkbp:is_linked_to |
biomarkers
patient outcomes treatment outcomes hypersensitivity reactions |
| gptkbp:is_part_of |
gptkb:vaccine
clinical trials immune response personalized medicine therapeutic interventions biomedical research therapeutic strategies treatment plans biological therapies therapeutic regimens |
| gptkbp:is_studied_in |
chronic diseases
various diseases biological effects chronic inflammatory diseases mechanisms of action |
| gptkbp:is_used_for |
targeted therapy
inflammatory conditions therapeutic purposes |
| gptkbp:is_used_in |
gptkb:healthcare_organization
research studies diagnostic tests clinical research vaccine development autoimmune therapy |
| gptkbp:is_utilized_in |
intravenous route
|
| gptkbp:monitors |
disease progression
|
| gptkbp:participated_in |
immune suppression
|
| gptkbp:produced_by |
B cells
laboratory settings recombinant DNA technology hybridoma technology |
| gptkbp:recognizes |
gptkb:protein
|
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:type_of |
gptkb:Ig_G
|